Price T Rowe Associates Inc. MD Sells 3,593,110 Shares of Celsius Holdings, Inc. (NASDAQ:CELH)

Price T Rowe Associates Inc. MD reduced its stake in shares of Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 47.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,016,568 shares of the company's stock after selling 3,593,110 shares during the quarter. Price T Rowe Associates Inc. MD owned about 1.71% of Celsius worth $105,797,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Champlain Investment Partners LLC acquired a new position in Celsius during the fourth quarter valued at approximately $85,068,000. Contrarius Group Holdings Ltd bought a new position in shares of Celsius during the fourth quarter worth $75,535,000. Norges Bank acquired a new position in shares of Celsius in the 4th quarter valued at $72,579,000. Raymond James Financial Inc. bought a new stake in shares of Celsius in the 4th quarter valued at $61,160,000. Finally, SG Americas Securities LLC raised its stake in Celsius by 10,320.0% during the 4th quarter. SG Americas Securities LLC now owns 1,932,813 shares of the company's stock worth $50,910,000 after buying an additional 1,914,264 shares during the period. 60.95% of the stock is owned by institutional investors.

Analyst Ratings Changes

CELH has been the subject of several recent analyst reports. Needham & Company LLC increased their price target on Celsius from $40.00 to $45.00 and gave the stock a "buy" rating in a report on Wednesday, April 9th. Roth Mkm reissued a "buy" rating and set a $38.00 target price on shares of Celsius in a research note on Friday, February 21st. UBS Group lifted their price target on shares of Celsius from $43.00 to $48.00 and gave the company a "buy" rating in a research note on Thursday, April 17th. JPMorgan Chase & Co. increased their price objective on shares of Celsius from $39.00 to $44.00 and gave the stock an "overweight" rating in a research report on Friday. Finally, LADENBURG THALM/SH SH cut their price objective on shares of Celsius from $62.00 to $58.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $46.88.

Celsius Trading Down 1.2 %

Shares of Celsius stock traded down $0.41 on Friday, reaching $34.46. 6,024,816 shares of the company were exchanged, compared to its average volume of 7,832,083. The company has a market capitalization of $8.88 billion, a price-to-earnings ratio of 78.32, a PEG ratio of 2.90 and a beta of 1.65. Celsius Holdings, Inc. has a one year low of $21.10 and a one year high of $98.85. The company has a 50-day moving average of $33.06 and a 200 day moving average of $29.58.

Celsius (NASDAQ:CELH - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.03. Celsius had a net margin of 10.70% and a return on equity of 51.89%. The firm had revenue of $332.20 million for the quarter, compared to analyst estimates of $326.07 million. Analysts predict that Celsius Holdings, Inc. will post 0.89 earnings per share for the current year.

Insider Activity at Celsius

In other Celsius news, insider Paul H. Storey sold 10,188 shares of the company's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $25.77, for a total value of $262,544.76. Following the transaction, the insider now directly owns 45,297 shares in the company, valued at $1,167,303.69. The trade was a 18.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Joyce Russell sold 4,000 shares of the firm's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total transaction of $113,880.00. Following the sale, the director now owns 19,106 shares of the company's stock, valued at approximately $543,947.82. This represents a 17.31 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.